Clinical Trial Update: A Study of MK-8109 (Vintafolide) Given Alone or With Chemotherapy in Participants With Advanced Cancers (MK-8109-001) [Phase 1]

View source ↗

Summary

A Phase 1 study of MK-8109 (Vintafolide) alone or with chemotherapy in participants with advanced cancers was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• MK-8109 (Vintafolide) (vintafolide)

Snippet

Sponsor: Endocyte | Conditions: Advanced Cancer | Phase 1 | Status: TERMINATED